Fast forward to the first quarter of 2026, and Intel has returned to meaningful growth -- even in a supply constrained ...

The SpaceX IPO is attracting a lot of attention, but one of its competitors is a better buy. SpaceX filed confidentially to ...

Adam Levy is a contributing Motley Fool stock market analyst covering technology, consumer, and financial stocks and how policy, economic, and consumer trends shape personal finance, Social Security ...

Sean Williams is a data-driven Motley Fool contributing analyst who's been investing for 27 years and has penned north of 15,000 articles. You'll find him at the intersection of politics and investing ...

Teva Pharmaceutical Industries ( TEVA +2.02%) will unveil its first-quarter results this Wednesday, April 29. Many Teva ...

After falling into bear market territory, Nvidia stock has come roaring back, climbing to a new all-time high. The ongoing ...

This is high-growth investing at its boldest. Powered by David Gardner's proven framework for identifying industry-changing ...

The company boasts a low cash payout ratio of just 42.3%, given it plenty of room for more payout increases. Gilead Sciences ...

Three sectors that could be the most at risk for share-price disruption are cybersecurity, banking, and cryptocurrency stocks. And among these sectors, a handful of companies could potentially feel ...

If Novo Nordisk's initiatives work and the company can cut the cost and time to develop drugs by even 5%, that could have a ...

The telecom giant's latest results highlighted impressive growth and strong guidance, further securing its robust dividend.

Eli Lilly is best known for its work in the weight loss market. The company has billion-dollar drugs in other areas. The ...